Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $106.0200 (2.99%) ($102.2450 - $106.0900) on Wed. Aug. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.21% (three month average) | RSI | 64 | Latest Price | $106.0200(2.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2.3% a day on average for past five trading days. | Weekly Trend | LGND advances 4.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(50%) IWN(50%) IWO(50%) IWC(48%) IBB(47%) | Factors Impacting LGND price | LGND will decline at least -1.605% in a week (0% probabilities). UUP(-17%) VXX(-16%) VIXM(-8%) TBT(-8%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.605% (StdDev 3.21%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $100.55(5.44%) | 10 Day Moving Average | $96.83(9.49%) | 20 Day Moving Average | $95.12(11.46%) | To recent high | 0% | To recent low | 42.5% | Market Cap | $1.704b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |